Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 211

1.

Genomic analysis of prostate cancer stem cells isolated from a highly metastatic cell line.

Rowehl RA, Crawford H, Dufour A, Ju J, Botchkina GI.

Cancer Genomics Proteomics. 2008 Nov-Dec;5(6):301-10.

2.

Phenotypic subpopulations of metastatic colon cancer stem cells: genomic analysis.

Botchkina IL, Rowehl RA, Rivadeneira DE, Karpeh MS Jr, Crawford H, Dufour A, Ju J, Wang Y, Leyfman Y, Botchkina GI.

Cancer Genomics Proteomics. 2009 Jan-Feb;6(1):19-29.

3.

Induction of metastatic cancer stem cells from the NK/LAK-resistant floating, but not adherent, subset of the UP-LN1 carcinoma cell line by IFN-γ.

Chen HC, Chou AS, Liu YC, Hsieh CH, Kang CC, Pang ST, Yeh CT, Liu HP, Liao SK.

Lab Invest. 2011 Oct;91(10):1502-13. doi: 10.1038/labinvest.2011.91. Epub 2011 Jun 20.

4.

Gene expression profiles of prostate cancer stem cells isolated by aldehyde dehydrogenase activity assay.

Nishida S, Hirohashi Y, Torigoe T, Kitamura H, Takahashi A, Masumori N, Tsukamoto T, Sato N.

J Urol. 2012 Jul;188(1):294-9. doi: 10.1016/j.juro.2012.02.2555. Epub 2012 May 16.

PMID:
22608744
5.

Sphere-forming cell subpopulations with cancer stem cell properties in human hepatoma cell lines.

Cao L, Zhou Y, Zhai B, Liao J, Xu W, Zhang R, Li J, Zhang Y, Chen L, Qian H, Wu M, Yin Z.

BMC Gastroenterol. 2011 Jun 14;11:71. doi: 10.1186/1471-230X-11-71.

6.

MicroRNA-320 suppresses the stem cell-like characteristics of prostate cancer cells by downregulating the Wnt/beta-catenin signaling pathway.

Hsieh IS, Chang KC, Tsai YT, Ke JY, Lu PJ, Lee KH, Yeh SD, Hong TM, Chen YL.

Carcinogenesis. 2013 Mar;34(3):530-8. doi: 10.1093/carcin/bgs371. Epub 2012 Nov 26.

PMID:
23188675
7.

Hierarchical organization of prostate cancer cells in xenograft tumors: the CD44+alpha2beta1+ cell population is enriched in tumor-initiating cells.

Patrawala L, Calhoun-Davis T, Schneider-Broussard R, Tang DG.

Cancer Res. 2007 Jul 15;67(14):6796-805. Erratum in: Cancer Res. 2007 Sep 15;67(18):8973.

8.

High aldehyde dehydrogenase and expression of cancer stem cell markers selects for breast cancer cells with enhanced malignant and metastatic ability.

Croker AK, Goodale D, Chu J, Postenka C, Hedley BD, Hess DA, Allan AL.

J Cell Mol Med. 2009 Aug;13(8B):2236-52. doi: 10.1111/j.1582-4934.2008.00455.x. Epub 2008 Aug 4.

9.

The Wnt/β-catenin pathway regulates self-renewal of cancer stem-like cells in human gastric cancer.

Cai C, Zhu X.

Mol Med Rep. 2012 May;5(5):1191-6. doi: 10.3892/mmr.2012.802. Epub 2012 Feb 21.

PMID:
22367735
10.

Analysis of multiple markers for cancer stem-like cells in human thyroid carcinoma cell lines.

Shimamura M, Nagayama Y, Matsuse M, Yamashita S, Mitsutake N.

Endocr J. 2014;61(5):481-90. Epub 2014 Feb 15.

11.

Established breast cancer stem cell markers do not correlate with in vivo tumorigenicity of tumor-initiating cells.

Lehmann C, Jobs G, Thomas M, Burtscher H, Kubbies M.

Int J Oncol. 2012 Dec;41(6):1932-42. doi: 10.3892/ijo.2012.1654. Epub 2012 Oct 5.

12.

ALDH activity indicates increased tumorigenic cells, but not cancer stem cells, in prostate cancer cell lines.

Yu C, Yao Z, Dai J, Zhang H, Escara-Wilke J, Zhang X, Keller ET.

In Vivo. 2011 Jan-Feb;25(1):69-76.

PMID:
21282737
13.

PC3 human prostate carcinoma cell holoclones contain self-renewing tumor-initiating cells.

Li H, Chen X, Calhoun-Davis T, Claypool K, Tang DG.

Cancer Res. 2008 Mar 15;68(6):1820-5. doi: 10.1158/0008-5472.CAN-07-5878.

14.

Side population is not necessary or sufficient for a cancer stem cell phenotype in glioblastoma multiforme.

Broadley KW, Hunn MK, Farrand KJ, Price KM, Grasso C, Miller RJ, Hermans IF, McConnell MJ.

Stem Cells. 2011 Mar;29(3):452-61. doi: 10.1002/stem.582.

15.

CD44+ CD133+ population exhibits cancer stem cell-like characteristics in human gallbladder carcinoma.

Shi C, Tian R, Wang M, Wang X, Jiang J, Zhang Z, Li X, He Z, Gong W, Qin R.

Cancer Biol Ther. 2010 Dec 1;10(11):1182-90. Epub 2010 Dec 1.

PMID:
20948317
16.

Suppression of telomerase, reexpression of KAI1, and abrogation of tumorigenicity by nerve growth factor in prostate cancer cell lines.

Sigala S, Faraoni I, Botticini D, Paez-Pereda M, Missale C, Bonmassar E, Spano P.

Clin Cancer Res. 1999 May;5(5):1211-8.

17.
18.

Aldehyde dehydrogenase activity of breast cancer stem cells is primarily due to isoform ALDH1A3 and its expression is predictive of metastasis.

Marcato P, Dean CA, Pan D, Araslanova R, Gillis M, Joshi M, Helyer L, Pan L, Leidal A, Gujar S, Giacomantonio CA, Lee PW.

Stem Cells. 2011 Jan;29(1):32-45. doi: 10.1002/stem.563.

19.

Trastuzumab (herceptin) targets gastric cancer stem cells characterized by CD90 phenotype.

Jiang J, Zhang Y, Chuai S, Wang Z, Zheng D, Xu F, Zhang Y, Li C, Liang Y, Chen Z.

Oncogene. 2012 Feb 9;31(6):671-82. doi: 10.1038/onc.2011.282. Epub 2011 Jul 11.

PMID:
21743497
20.

Long-term maintenance of brain tumor stem cell properties under at non-adherent and adherent culture conditions.

Inagaki A, Soeda A, Oka N, Kitajima H, Nakagawa J, Motohashi T, Kunisada T, Iwama T.

Biochem Biophys Res Commun. 2007 Sep 28;361(3):586-92. Epub 2007 Jul 18.

PMID:
17673180

Supplemental Content

Support Center